gettyimages-1252004424-vth.jpg
PE Fundraising

LPs seek recession hedge with PE healthcare funds

Unlike VC’s short-lived spike in life sciences fundraising, the post-COVID bump in fundraising for PE healthcare investments has proved to be a long-term step-up.

A pandemic-induced spike in private healthcare investing has proved more durable for private equity than venture capital.

Specialist PE firms that focus on healthcare have maintained a furious pace of fresh capital commitments since 2021’s 93% year-over-year surge in fundraising, reaching $18.3 billion that year, according to PitchBook’s H1 2023 Healthcare Funds Report.

Meanwhile, VC life sciences investors reversed the 108% jump in fundraising they enjoyed between 2020 and 2021 in just one year. After raising $29.6 billion in 2021, commitments to VC life sciences funds plummeted 56% in 2022—raising even less than in 2020.

 

Why the divergence? While both VC and PE investors experienced a wave of pandemic-related interest in healthcare—specifically biotechnology, in the case of VC—other economic forces made healthcare companies attractive PE investments, said PitchBook analyst Rebecca Springer, author of the report.

“We moved from a recession to a pandemic to another potential recession, and all three of those play into healthcare,” which some investors see as a hedge against any broader GDP slowdown, Springer said.

PE’s strength in healthcare-specific fundraising also bucks a broader trend of slumping capital commitments for the strategy this year. Overall global PE fundraising dipped 20% from 2021 to 2022, and commitments were tracking even lower in Q1 2023, according to PitchBook’s latest Global Private Market Fundraising Report.

Some limited partners are inspired to allocate dollars to healthcare specialists because of those managers’ focus on operations, Springer added.

“Specialist managers can tell a compelling story about the level of operational expertise that they’re willing or able to bring to the table,” she said. “And I think the industry has really moved toward valuing that operational expertise more over time, as opposed to just financial engineering.”

A single fund accounts for more than a quarter of PE healthcare fundraising so far this year: first-timer Patient Square Capital closed its fund in Q1 on $3.9 billion, which the firm said was the largest inaugural PE fund ever raised and the largest healthcare specialist fund across PE, VC and growth capital.

Other recent closes include Martis Capital Management‘s fourth fund on $779 million; WindRose Health Investors’ sixth fund on over $1.4 billion; and Varsity Healthcare Partners’ fourth fund on $700 million.

Beyond specialty healthcare investors—whose deals account for a fraction of all PE healthcare activity—an estimated $125.4 billion is on hand for all European and North American asset managers to deploy in the sector, according to the report.


Featured image by picture alliance /Getty Images

Learn about our editorial standards.